X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (19) 19
flavonoids (15) 15
humans (13) 13
food science & technology (12) 12
phenolic-compounds (9) 9
metabolism (8) 8
absorption (7) 7
bioavailability (7) 7
caco-2 cells (7) 7
chemistry, applied (7) 7
by-products (6) 6
food (6) 6
metabolites (6) 6
polyphenols (6) 6
aged (5) 5
agriculture, multidisciplinary (5) 5
analysis (5) 5
animals (5) 5
female (5) 5
isoflavones (5) 5
male (5) 5
mass spectrometry (5) 5
middle aged (5) 5
quercetin (5) 5
abridged index medicus (4) 4
bioflavonoids (4) 4
brassica - chemistry (4) 4
cardiovascular disease (4) 4
cardiovascular diseases (4) 4
flavones (4) 4
flavonoids - metabolism (4) 4
glycosides (4) 4
mass-spectrometry (4) 4
molecular structure (4) 4
myocardial infarction (4) 4
phenolics (4) 4
safety and security measures (4) 4
agriculture and food sciences (3) 3
angina (3) 3
antioxidant activity (3) 3
biochemical research methods (3) 3
biology and life sciences (3) 3
cardiovascular diseases - mortality (3) 3
care and treatment (3) 3
cerebral infarction (3) 3
chemistry, analytical (3) 3
dietary polyphenols (3) 3
double-blind method (3) 3
flavonoid glycosides (3) 3
flavonoids - chemistry (3) 3
foods (3) 3
health risk assessment (3) 3
identification (3) 3
intestine (3) 3
kaempferol (3) 3
liquid chromatography (3) 3
medicine (3) 3
medicine, general & internal (3) 3
metabolomics (3) 3
model (3) 3
myocardial-infarction (3) 3
obstructive pulmonary-disease (3) 3
permeability (3) 3
phenols - chemistry (3) 3
plant extracts - chemistry (3) 3
research (3) 3
respiratory system (3) 3
risk (3) 3
science (3) 3
studies (3) 3
usage (3) 3
abc transporters (2) 2
abstracts (2) 2
acephala var. sabellica (2) 2
acute coronary syndrome (2) 2
acute coronary syndromes (2) 2
adult (2) 2
angina pectoris (2) 2
anthocyanins (2) 2
antioxidant (2) 2
antioxidants (2) 2
association (2) 2
bioconversion (2) 2
biological activity (2) 2
bound phenolics (2) 2
cancer (2) 2
cardiac & cardiovascular systems (2) 2
cardiovascular diseases - prevention & control (2) 2
cauliflower waste (2) 2
chromatography, high pressure liquid (2) 2
clinical trials (2) 2
copd (2) 2
coronary artery disease (2) 2
coumaric acids - analysis (2) 2
critical care medicine (2) 2
diabetes (2) 2
diabetes mellitus (2) 2
diabetes mellitus, type 2 - complications (2) 2
diabetes mellitus, type 2 - drug therapy (2) 2
digestion - physiology (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of Thoracic and Cardiovascular Surgery, ISSN 0022-5223, 1999, Volume 118, Issue 3, pp. 518 - 528
Journal Article
The Atlanta Constitution, 01/2001
  Thank you for running an open-minded article about breast-feeding right next to the commentary from John Rosemond ("State errs in breast-feeding case,"... 
Attendance | Letters to the editor | Municipal government
Newspaper Article
BusinessWorld, ISSN 0116-3930, 06/2003, p. 1
I really expected Jacky Chan to make a grand entrance at a sprawling function room in one posh Makati hotel that night when I was assigned to attend the launch... 
Journal Article
BusinessWorld, ISSN 0116-3930, 05/2003, p. 1
Manuel B. Abad, program manager of DTI-CARP, said DTI-CARP is in charge of the "off-farm aspects" of agricultural production. Farmers in barangay Mandaug,... 
Journal Article
Chest, ISSN 0012-3692, 08/2009, Volume 136, Issue 2, pp. 396 - 404
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 14, pp. 1327 - 1335
Alogliptin, a new antihyperglycemic agent of the DPP-4 class, was shown to have no significant effect on cardiovascular risk over a median treatment period of... 
INHIBITOR ALOGLIPTIN | MEDICINE, GENERAL & INTERNAL | CARDIOVASCULAR SAFETY | MELLITUS | OUTCOMES | MYOCARDIAL-INFARCTION | Hypoglycemic Agents - therapeutic use | Double-Blind Method | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Uracil - therapeutic use | Male | Myocardial Infarction - complications | Myocardial Infarction - drug therapy | Uracil - adverse effects | Angina, Unstable - drug therapy | Piperidines - therapeutic use | Angina, Unstable - complications | Piperidines - adverse effects | Cardiovascular Diseases - mortality | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Uracil - analogs & derivatives | Type 2 diabetes | Care and treatment | Acute coronary syndrome | Patient outcomes | Risk factors | Myocardial infarction | Heart attacks | Cardiovascular disease | Angina | Drug development | Hemoglobin | Diabetes mellitus (non-insulin dependent) | Drug dosages | Cerebral infarction | Stroke | Peptidase | Statistical analysis | Diabetes mellitus | Pancreatitis | Committees | FDA approval | Hypoglycemia | Angina pectoris | Studies | Product development | Diabetes | Acute coronary syndromes | Cardiovascular diseases | Health risk assessment | Cancer
Journal Article